EXAMINE THIS REPORT ON MBL77

Not all sufferers with CLL involve therapy. Irrespective of all latest developments, the iwCLL nonetheless recommends watchful observation for people with asymptomatic condition.86 This advice relies on not less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).10